M. Jolicoeur

796 total citations
29 papers, 263 citations indexed

About

M. Jolicoeur is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, M. Jolicoeur has authored 29 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiation and 6 papers in Surgery. Recurrent topics in M. Jolicoeur's work include Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Advanced Radiotherapy Techniques (8 papers). M. Jolicoeur is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Advanced Radiotherapy Techniques (8 papers). M. Jolicoeur collaborates with scholars based in Canada, Switzerland and France. M. Jolicoeur's co-authors include Jacques Paiement, David Donath, B. Fortin, Thu Van Nguyen, David H. Nguyen, Frederick W. K. Kan, Christoph Oehler, Sawyna Provencher, Sophie Lavertu and Diane Provencher and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Cell Biology and Annals of the New York Academy of Sciences.

In The Last Decade

M. Jolicoeur

25 papers receiving 262 citations

Peers

M. Jolicoeur
Nathalie Casanova Switzerland
M.M. Boisen United States
Chad Winch Canada
Jesus E. Juarez United States
M. Jolicoeur
Citations per year, relative to M. Jolicoeur M. Jolicoeur (= 1×) peers Makbule Tambaş

Countries citing papers authored by M. Jolicoeur

Since Specialization
Citations

This map shows the geographic impact of M. Jolicoeur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Jolicoeur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Jolicoeur more than expected).

Fields of papers citing papers by M. Jolicoeur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Jolicoeur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Jolicoeur. The network helps show where M. Jolicoeur may publish in the future.

Co-authorship network of co-authors of M. Jolicoeur

This figure shows the co-authorship network connecting the top 25 collaborators of M. Jolicoeur. A scholar is included among the top collaborators of M. Jolicoeur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Jolicoeur. M. Jolicoeur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guévelou, Jennifer Le, Thomas Zilli, L. Ferretti, et al.. (2024). Urinary Organs at Risk for Prostate Cancer External Beam Radiation Therapy: Contouring Guidelines on Behalf of the Francophone Group of Urological Radiation Therapy. Practical Radiation Oncology. 14(6). 541–554. 3 indexed citations
2.
Niazi, Tamim, Abdenour Nabid, Talía Malagón, et al.. (2024). Hypofractionated Dose Escalation Radiotherapy for High-Risk Prostate Cancer: the survival analysis of the Prostate Cancer Study-5 (PCS-5), a GROUQ-led phase III trial. European Urology. 87(3). 314–323. 3 indexed citations
3.
Niazi, Tamim, Abdenour Nabid, Talía Malagón, et al.. (2023). Hypofractionated, Dose Escalation Radiation Therapy for High-Risk Prostate Cancer: The Safety Analysis of the Prostate Cancer Study-5, a Groupe de Radio-Oncologie Génito-Urinaire de Quebec Led Phase 3 Trial. International Journal of Radiation Oncology*Biology*Physics. 118(1). 52–62. 9 indexed citations
4.
Sargos, Paul, O. Chapet, M. Jolicoeur, et al.. (2023). Managing postoperative biochemical relapse in prostate cancer, from the perspective of the Francophone group of Urological radiotherapy (GFRU). Cancer Treatment Reviews. 120. 102626–102626. 2 indexed citations
5.
Zilli, Thomas, M. Jolicoeur, G. Créhange, et al.. (2023). Consensus Delineation Guidelines for Pelvic Lymph Node Radiation Therapy of Prostate Cancer: On Behalf of the Francophone Group of Urological Radiation Therapy (GFRU). International Journal of Radiation Oncology*Biology*Physics. 118(1). 29–40. 10 indexed citations
7.
Tsui, James Man Git, Michael Jonathan Kucharczyk, Abdenour Nabid, et al.. (2021). The Clinical Significance of Bone Mineral Density Changes Following Long-Term Androgen Deprivation Therapy in Localized Prostate Cancer Patients. The Journal of Urology. 205(6). 1648–1654. 4 indexed citations
8.
Jolicoeur, M., et al.. (2021). PP-0121 HDR Brachytherapy as Monotherapy for Prostate Cancer: Early Toxicity of a Randomized Phase II Trial. Radiotherapy and Oncology. 158. S90–S91. 1 indexed citations
9.
Robin, Sophie, M. Jolicoeur, Thomas Zilli, et al.. (2020). Prostate Bed Delineation Guidelines for Postoperative Radiation Therapy: On Behalf Of The Francophone Group of Urological Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 109(5). 1243–1253. 29 indexed citations
10.
Jolicoeur, M., et al.. (2017). Long-Term Follow-up for High-Dose-Rate Interstitial Brachytherapy and Lumpectomy as a Second Conservative Treatment for Local Recurrences of Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 99(2). S6–S6.
11.
Marquis‐Gravel, Guillaume, Robert Avram, Maxime Tremblay‐Gravel, et al.. (2015). BROMOCRIPTINE FOR THE TREATMENT OF PERIPARTUM CARDIOMYOPATHY: A CASE CONTROL STUDY ACROSS ACADEMIC CENTERS IN QUÉBEC. Canadian Journal of Cardiology. 31(10). S293–S293. 1 indexed citations
12.
13.
Menkarios, C., Éric Vigneault, David H. Nguyen, et al.. (2011). Toxicity report of once weekly radiation therapy for low-risk prostate adenocarcinoma: preliminary results of a phase I/II trial. Radiation Oncology. 6(1). 112–112. 21 indexed citations
14.
Provencher, Sawyna, Christoph Oehler, Sophie Lavertu, et al.. (2010). Quality of life and tumor control after short split-course chemoradiation for anal canal carcinoma. Radiation Oncology. 5(1). 41–41. 38 indexed citations
15.
Petignat, Patrick, M. Jolicoeur, Abdulaziz Alobaid, et al.. (2005). Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrence. Gynecologic Oncology. 101(3). 445–449. 40 indexed citations
16.
Jolicoeur, M., et al.. (1998). 2Combined re-exicision and perioperative interstitial brachytherapy for salvage of breast conservation therapy recurrences. Radiotherapy and Oncology. 47. S1–S1. 1 indexed citations
17.
Jolicoeur, M., et al.. (1997). 2037 Combined re-exicision and perioperative interstitial brachytherapy for salvage of breast conservation therapy recurrences. International Journal of Radiation Oncology*Biology*Physics. 39(2). 259–259. 3 indexed citations
18.
Kan, Frederick W. K., M. Jolicoeur, & Jacques Paiement. (1992). Freeze-fracture analysis of the effects of intermediates of the phosphatidylinositol cycle on fusion of rough endoplasmic reticulum membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1107(2). 331–341. 15 indexed citations
19.
Jolicoeur, M., Frederick W. K. Kan, & Jacques Paiement. (1991). Synthesis of CDP-diacylglycerol by rat liver rough microsomes as visualized by electron microscopic autoradiography: relationship to GTP-stimulated membrane fusion.. Journal of Histochemistry & Cytochemistry. 39(3). 363–372. 7 indexed citations
20.
Lavoie, Christine, M. Jolicoeur, & Jacques Paiement. (1991). Accumulation of polyunsaturated free fatty acids coincident with the fusion of rough endoplasmic reticulum membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1070(1). 274–278. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026